Back to results
US 2020/0267986 A1Published application
Microbiocidal Oxadiazole Derivatives
AssigneeSyngenta Participations AG
InventorsFarhan BOU HAMDAN, Daniel STIERLI, Stephane André Marie JEANMART, Christopher Richard Ayles GODFREY, Thomas James HOFFMAN, Renaud BEAUDEGNIES, Martin POULIOT
Life of this patent
Estimating the term…
Abstract
Compounds of the formula (I) wherein the substituents are as defined in claim 1, useful as a pesticides and especially as fungicides.
Claims20
A compound of formula (I):
- wherein
- R1 is hydrogen;
- R2 is halogen, methyl or methoxy;
- R3 represents hydrogen or C1-4alkyl;
- and
- R4 represents R4A, R4B, R4C, R4D or R4E;
- wherein
- R4A represents heterocyclylC0-6alkyl wherein the heterocyclyl moiety is a 5- or 6-membered non-aromatic ring which comprises 1, 2 or 3 heteroatoms individually selected from N, O and S, optionally substituted by 1, 2 or 3 substituents, which may be the same or different, selected from R5A;
- R5A represents C1-4alkyl, C1-4alkoxy, C1-4alkoxycarbonyl, phenylC0-2alkyl;
- R4B represents C3-8cycloalkylC0-1-alkyl optionally substituted by 1, 2, 3 or 4 substituents, which may be the same or different, selected from R5B;
- R5B represents cyano, halogen, C1-4alkyl, C2-4alkynyl, C1-4alkoxycarbonyl, C3-6cycloalkylC0-2alkyl, phenylC0-2alkyl, and wherein any of said cycloalkyl or phenyl moieties are optionally substituted by 1, 2 or 3 substituents, which may be the same or different, selected from R6B;
- and
- R6B represents methyl, methoxy or halogen;
- R4C represents C1-6alkyl, C2-6alkenyl or C2-6alkynyl, wherein C1-6alkyl is optionally substituted by 1, 2 or 3 substituents, which may be the same or different, selected from R5C;
- R5C represents halogen, C1-4alkoxy, C1-4alkylcarbonyl, C1-4alkoxycarbonyl, hydroxyl, C1-4 alkylaminocarbonyl;
- R4D represents a phenylC0-1-alkyl optionally substituted by 1, 2, 3, 4 or 5 substituents, which may be the same or different, selected from R5D;
- R5D represents cyano, halogen, hydroxy, C1-4alkyl, C2-4alkenyl, C2-4alkynyl, haloC1-4alkyl, C1-4alkoxy, C1-4alkylcarbonyl, C1-4alkoxycarbonyl, aminocarbonyl, C1-4alkylaminocarbonyl, diC1-4alkylaminocarbonyl, C1-4alkoxycarbonylamino, C3-8cycloalkylC0-6alkyl, phenylC0-6alkyl, heteroarylC0-6alkyl wherein the heteroaryl moiety is a 5- or 6-membered aromatic ring which comprises 1, 2, 3 or 4 heteroatoms individually selected from N, O and S, heterocyclylC0-6alkyl wherein the heterocyclyl moiety is a 5- or 6-membered non-aromatic ring which comprises 1, 2 or 3 heteroatoms individually selected from N, O and S, and wherein any of said cycloalkyl, phenyl, heteroaryl and heterocyclyl moieties are optionally substituted by 1, 2, 3, 4 or 5 substituents, which may be the same or different, selected from R6D;
- and
- R6D represents methyl, methoxy or halogen;
- and
- R4E represents heteroarylC0-6alkyl wherein the heteroaryl moiety is a 5- or 6-membered aromatic ring comprising 1, 2, 3 or 4 heteroatoms individually selected from N, O and S, and wherein the heteroarylC0-6alkyl moiety is optionally substituted by 1, 2, 3, 4 or 5 substituents, which may be the same or different, selected from R5E;
- R5E represents cyano, amino, halogen, hydroxy, C1-4alkyl, C2-4alkenyl, C2-4alkynyl, haloC1-4 alkyl, C1-4alkoxy, C1-4alkylamino, diC1-4alkylamino, C1-4alkylcarbonyl, C1-4alkoxycarbonyl, aminocarbonyl, C1-4alkylaminocarbonyl, diC1-4alkylaminocarbonyl, C1-4alkoxycarbonylamino, C3-8cycloalkylC0-6alkyl, phenylC0-6alkyl, heteroarylC0-6alkyl wherein the heteroaryl moiety is a 5- or 6-membered aromatic ring which comprises 1, 2, 3 or 4 heteroatoms individually selected from N, O and S, heterocyclylC0-6alkyl wherein the heterocyclyl moiety is a 5- or 6-membered non-aromatic ring which comprises 1, 2 or 3 heteroatoms individually selected from N, O and S, and wherein any of said cycloalkyl, phenyl, heteroaryl and heterocyclyl are optionally substituted by 1, 2, 3, 4 or 5 substituents, which may be the same or different, selected from R6E;
- and
- R6E represents methyl, methoxy or halogen;
- or a salt or an N-oxide thereof;
- wherein
- when R4 is R4A, the compound according to Formula (I) is not:
- 2-fluoro-N-(pyrrolidin-3-yl)-4-[(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)]benzamide,
- 2-fluoro-N-(1-(pyrrolidin-1-yl)propan-2-yl)-4-[(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)]benzamide,
- 2-fluoro-N-(1-(piperidin-1-yl)propan-2-yl)-4-[(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)]benzamide,
- 2-fluoro-N-(1-morpholinopropan-2-yl)-4-[(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)]benzamide, or
- 2-fluoro-N-(4-methoxypyrrolidin-3-yl)-4-[(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)]benzamide;
- when R4 is R4C, the compound according to Formula (I) is not:
- 2-fluoro-N-(1-hydroxypropan-2-yl)-4-[(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)]benzamide;
- and
- when R4 is R4E, the compound according to Formula (I) is not:
- N-(2,6-dimethylpyridin-4-yl)-2-fluoro-4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzamide.
34 more elements
Dependencies are inferred from the claim text.